AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.27M | -292.30K | -1.90M | 328.50K | -3.72M |
| Total Depreciation and Amortization | 108.10K | 108.00K | 106.80K | 106.80K | 106.80K |
| Total Amortization of Deferred Charges | 60.60K | 60.10K | 50.00K | 49.80K | 41.50K |
| Total Other Non-Cash Items | 1.19M | 147.20K | 1.08M | -993.60K | 2.94M |
| Change in Net Operating Assets | 1.46M | -1.09M | 687.70K | 244.00K | -12.50K |
| Cash from Operations | 553.00K | -1.07M | 19.60K | -264.50K | -643.60K |
| Capital Expenditure | 0.00 | -2.80K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -2.80K | -- | -- | -- |
| Total Debt Issued | 100.00K | 100.00K | 100.00K | 0.00 | 575.00K |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | 910.20K | 13.70K | 190.20K | 112.60K |
| Repurchase of Common Stock | -743.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -643.70K | 1.01M | 113.70K | 190.20K | 687.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.70K | -59.70K | 133.20K | -74.30K | 44.00K |
